References
- Gleichmann E, Gleichmann H. Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. I: Autoimmune hemolytic anemia. Eur J Immunol 1976; 6: 899–906
- van tier Veen F, Rolink A G, Gleichmann E. Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. II. Autoantibodies to nuclear antigens. Clin Exp Immunol 1981; 46: 589–596
- van der Veen J PW, Rolink A G, Gleichmann E. Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. III. Autoantibodies to thymocytes. J Immunol 1981; 127: 1281–1286
- Gleichmann E, van Elven E H, van der Veen J PW. A systemic lupus erythemalosus(SLE)‐like disease in mice induced by abnormal T.‐B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur J Immunol 1982; 12: 153–159
- Simonsen M, Jensen E. The graft versus host assay in transplantation chimaeras. Biological Problems of Crofting, F Albert, D B Medawar. Blackwell Scientific Publications, Oxford 1959; 271–300
- van Rappard‐van der Veen F M, Rolink A G, Gleichmann E. Diseases caused by reactions of T lymphocytes towards incompatible structures of the major histocompatibility complex. VI. Autoantibodies characteristic of systemic lupus erythematosus induced by abnormal T.‐B cell cooperation across I.‐E. J Exp Med 1982; 155: 1555–1560
- Rolink A G, Gleichmann E. Allosuppressor‐ and allohelper‐T cells in acute and chronic graft‐vs.‐host (GVH) disease. /. Exp Med 1983; 158: 546–558
- Ussing A P. Graft‐Versus‐Host Reaction and Autoimmune Disease in Mice. Thesis (in Danish), Statens Seruminstitut, Copen‐agenDenmark 1986
- Ussing A P, Prause J U, Sparck J V. SLE and Sjogren's syndrome in transplantation chimeras. The GVH mouse as a model for autoimmune disease. Scand J Immunol 1988; 28: 267, (abstract)
- Sorensen I, Ussing A P, Prause J U, Blom J, Larsen S, Sparck J V. Histopathological changes in exocrine glands of murine transplantation chimeras. I: The development of Sjogren's syndrome‐like changes secondary to GVH induced lupus syndrome. Autoimmunity 1992; 11: 261–271
- Doenhoff M J, Davies A JS, Leuchars E, Wallis V. The thymus and circulating antibodies of mice. Proc Roy Soc Lond B 1970; 176: 69–85
- Hpier‐Madsen M, Kristensen F B, Møller S. Demonstration and titration of organ‐non‐specific antinuclear antibodies (ANA) in serum by means of indirect immunofluoresence technique with cultured human fibroblasts as nuclear substrate. Ugeskr Laeger 1982; 144: 1840–1845
- Kristensen F B, Høier‐Madsen M, Møller S. Organ‐non‐specific antinuclear antibodies (ANA) demonstrated on cultured human fibroblasts compared with a single graduation of fluorescence intensity on rat liver sections. Ugeskr Laeger 1982; 144: 1845–1848
- Chrisholm D M, Mason D K. Labial salivary gland biopsy in Sjogren's disease. Clin Pathol 1986; 21: 656–660
- Daniels T E. Labial salivary gland biopsy in Sjogren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984; 27: 147–156
- Buerkert J E. Obstructive uropathy. Renal Pathology with Clinical and Functional Correlations, C C Tischer, B M Brenner. J. B. Lippincott Company. 1989; 809–843
- Prause J U, Jensen O A, Manthorpc R. Effect of bromhexine, ambroxol and placebo on clinical and histopathological changes in “Sjogren” mice. Graefes Arch Clin Exp Ophthalmol 1985; 233: 259–264
- Sjögren H. Keratoconjunctivitis sicca och siccasyndromet. OpusclMed 1963; 8: 3–11
- Jacobsen L TH, AxeTl T E, Hansen B U, Henricsson V J, Larsson Å, Lieberkind K, Lilja B, Manthorpe R. Dry eyes or mouth–an epidemiological study in Swedish adults, with special reference to primary Sjogren's syndrome. Sjogren's Syndrome: A Model for Understanding Autoimmunity, N Talal. Academic Press. 1989; 213–219
- Gratwohl A A, Moutsopoulos H M, Chused T M, Akizuki M, Wolf R O, Sweet J B, Deisseroth J B. Sjogren‐type syndrome after allogeneic bone‐marrow transplantation. Ann Intern Med 1977; 87: 703–706
- Holmes J A, Livesey S J, Bedwell A E, Amos N, Whittaker J A. Autoantibody analysis in chronic graft‐versus‐host disease. Bone Marrow Transplant 1989; 4: 529–531
- Møller J, Dickmeiss E, Ryder L P, Jacobsen N, Svejgaard A. Increased frequencies of the CD29 and CD57 markers and decreased frequencies of CD45RA within CD4+ and CD8+ subsets after allogeneic BMT in man. Scand J Immunol 1991; 33: 499–506
- Morimoto C, Steinberg A D, Letvin N L, Hagan M, Takeuchi T, Daley J, Levine H, Schlosman S F. A defect of immunoregula‐tory T cell subsets in patients demonstrated with anti‐2H4 antibody. J Clin Invest 1987; 79: 762–768
- Morimoto C, Hafler D A, Weiner H L, Letvin N L, Hagan M, Daley J, Schlossman S F. Selective loss of the suppressor‐inducer T cell subset in progressive multiple schlerosis: Analysis with anti‐2H4 monoclonal antibody. N Eng J Med 1987; 316: 67–72
- Eichwald E J, Silsmer C R, Wheeler N. The genetics of skin grafting. Ann New York Acad Sci 1957; 64: 737–740
- Eichwald E J, Lustgraaf E C. Problems in transplantation immunity. Ann New York Acad Sci 1958; 73: 777–781
- van Elven E H, Rolink A G, van der Veen F, Gleichmann E. Capacity of genetically different T lymphocytes to induce lethal graft‐versus‐host disease correlates with their capacity to generate suppression but not with their capacity to generate anti‐F, killer cells. A non‐H‐2 locus determines the inability to induce lethal graft‐versus‐host disease. J Exp Med 1981; 153: 1474–1488
- van Rappard‐Du van der Veen F M, Radaskiewicz R, Terraneo L, Gleichmann E. Attempts at standardization of lupus‐like graft‐vs‐host disease: Inadvertent repopulation by DBA/2 spleen cells of H‐2‐different nonirradiated F., mice. J Immunol 1983; 130: 2693–2701
- Bruijn J A, Elvan E H, Hogendoorn P CW, Corver W E, Hoede‐maeker P J, Fleuren G J. Murine chronic graft‐versus‐host disease as a model for lupus disease. Amer J Pathol 1988; 130: 639–641